These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 330389)

  • 1. The origin and mechanism of the allograft reaction.
    Lafferty KJ; Woolnough J
    Immunol Rev; 1977; 35():231-62. PubMed ID: 330389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of thyroid allograft rejection.
    Lafferty KJ; Bootes A; Killby VA; Burch W
    Aust J Exp Biol Med Sci; 1976 Dec; 54(6):573-86. PubMed ID: 1027412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of organ culture on the survival of thyroid allografts in mice.
    Lafferty KJ; Bootes A; Dart G; Talmage DW
    Transplantation; 1976 Aug; 22(2):138-49. PubMed ID: 61634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
    Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
    Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of thyroid allograft survival following organ culture. Alteration of tissue immunogenicity.
    Hullett DA; Landry AS; Leonard DK; Sollinger HW
    Transplantation; 1989 Jan; 47(1):24-7. PubMed ID: 2911873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The basis of immunogenicity of endocrine allografts.
    Nicolls MR; Coulombe M; Gill RG
    Crit Rev Immunol; 2001; 21(1-3):87-101. PubMed ID: 11642616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells.
    Isakov N; Segal S
    Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of rejection by treatment of the graft: an overview.
    Lafferty KJ; Babcock SK; Gill RG
    Prog Clin Biol Res; 1986; 224():87-117. PubMed ID: 2948196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection of cultured thyroid allografts by the transfer of sensitized LYT 2+ T cells.
    Warren HS; Pembrey RG
    Transplantation; 1986 Apr; 41(4):421-6. PubMed ID: 3083539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism.
    Zhang Z; Kaptanoglu L; Haddad W; Ivancic D; Alnadjim Z; Hurst S; Tishler D; Luster AD; Barrett TA; Fryer J
    J Immunol; 2002 Apr; 168(7):3205-12. PubMed ID: 11907073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity.
    Wagner H; Röllinghoff M; Nossal GJ
    Transplant Rev; 1973; 17(0):3-36. PubMed ID: 4151904
    [No Abstract]   [Full Text] [Related]  

  • 15. Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts.
    Tourneur L; Malassagne B; Batteux F; Fabre M; Mistou S; Lallemand E; Lores P; Chiocchia G
    J Immunol; 2001 Aug; 167(3):1338-46. PubMed ID: 11466351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts.
    Markmann JF; Campos L; Bhandoola A; Kim JI; Desai NM; Bassiri H; Claytor BR; Barker CF
    Surgery; 1994 Aug; 116(2):242-8; discussion 248-9. PubMed ID: 8047991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic requirements for triggering of cytotoxic T lymphocytes.
    Bach FH; Grillot-Courvalin C; Kuperman OJ; Sollinger HW; Hayes C; Sondel PM; Alter BJ; Bach ML
    Immunol Rev; 1977; 35():76-96. PubMed ID: 142746
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunobiology of rejection and adaptation.
    Trivedi HL
    Transplant Proc; 2007 Apr; 39(3):647-52. PubMed ID: 17445565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection.
    Talmage DW; Dart G; Radovich J; Lafferty KJ
    Science; 1976 Jan; 191(4225):385-8. PubMed ID: 1082167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model.
    Pollak R; Blanchard JM
    Transplantation; 2000 Jun; 69(11):2432-9. PubMed ID: 10868654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.